Statement from the Clinical Effectiveness Unit: Combined hormonal contraception and venous thromboembolism (December 2016)

Posted 12 December 2016

Date: 12 Dec 2016

Type: FSRH Clinical Guidance and Clinical Statements

A short documentary hosted on the Guardian website highlights some fatal cases of venous thrombosis that were associated with use of combined hormonal contraception.

The programme interviews the families of young American women who have died as a result of venous thromboembolic events that occurred while they were using the combined hormonal contraceptives NuvaRing® and Yaz®. The CEU considers it important to put the documentary into perspective.

Read the Statement in full below.